Increasing digitalization is anticipated to propel growth of the global connected drug delivery devices market. Fortune Business Insights has recently announced a report, titled “Connected Drug Delivery Devices Market Size, Share and Global Trend By Product Type (Sensors, Integrated devices), Application (Diabetes, Multiple Sclerosis, Asthma and COPD, Hypertension), End Users (Home Care Settings, Hospitals, Surgical Centers) and Geography Forecast till 2026” to study various factors influencing the market’s trajectory. The increasing adoption of mobile apps for medical purposes is expected to increase the growth rate in the market.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/connected-drug-delivery-devices-market-100380
On the basis of region, in 2018 North America accounted for a considerable share in the global market. The region is expected to keep exhibiting impressive growth through the forecast period 2019-2026. The high presence of key market players, gives North America edge over other regional markets for connected drug delivery. Moreover, technological advancements in drug delivery devices is anticipated to contribute towards market expansion. Europe is projected to emerge as one of the lucrative markets. The region is witnessing high demand for home treatment. Furthermore, favorable reimbursement policies will drive the market in the region.
Key Segmentation:
By Product Type
- Sensors
- Integrated devices
By Application
- Diabetes
- Multiple Sclerosis
- Asthma and COPD
- Hypertension
By End User
- Home Care Settings
- Hospitals
- Surgical Centers
- Others
By Geography
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East and Africa (South Africa, GCC and Rest of Middle East and Africa)
Besides this, the Asia Pacific connected drug delivery devices market is likely to witness lucrative growth prospects. Owing to the high prevalence of chronic disorders in the region, the market is likely to witness a steep growth. The increasing healthcare expenditure in the region is further expected to contribute towards the market growth.
Get Sample PDF Brochure:
AptarGroup, Inc., and Propeller Health Sets Higher Standards for Other Players
The U.S. Food and Drug Administration approved AliveCor, Inc.’s new product, KardiaBand. The devices are enabled with personal electrocardiogram, to detect sinus heart rhythms and atrial fibrillation. Development of new devices is further expected to increase growth potential of the global connected drug delivery devices market.
The competition among the market players is increasing owing to the prevailing opportunities in the market. Certain players are focusing on product development to establish a stronger foothold in the market. Some players are involved in partnership and mergers and acquisition to attain a strong brand presence. For instance, AptarGroup, Inc., and Propeller Health partnered in 2018.
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:sales@fortunebusinessinsights.com
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Connected Drug Delivery Devices Market Size Overview by Industry Trends, Share, Growth Factor and Analysis to 2026
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
